| Literature DB >> 35223800 |
Alex Ede Danku1, Eva-H Dulf1, Cornelia Braicu2, Ancuta Jurj2, Ioana Berindan-Neagoe2.
Abstract
Organ-on-a-chip (OoC), also known as micro physiological systems or "tissue chips" have attracted substantial interest in recent years due to their numerous applications, especially in precision medicine, drug development and screening. Organ-on-a-chip devices can replicate key aspects of human physiology, providing insights into the studied organ function and disease pathophysiology. Moreover, these can accurately be used in drug discovery for personalized medicine. These devices present useful substitutes to traditional preclinical cell culture methods and can reduce the use of in vivo animal studies. In the last few years OoC design technology has seen dramatic advances, leading to a wide range of biomedical applications. These advances have also revealed not only new challenges but also new opportunities. There is a need for multidisciplinary knowledge from the biomedical and engineering fields to understand and realize OoCs. The present review provides a snapshot of this fast-evolving technology, discusses current applications and highlights advantages and disadvantages for biomedical approaches.Entities:
Keywords: microfluidics; nanotechnology; organs-on-a-chip; personalized medicine; technical details
Year: 2022 PMID: 35223800 PMCID: PMC8866728 DOI: 10.3389/fbioe.2022.840674
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Multi-organ chip platform for disease modeling.
Summary for organs that have been recreated using organ-on-a-chip models.
| Organ | Main characteristic | References |
|---|---|---|
| Liver | Maintains physiologic properties; |
|
| Great regenerative properties; | ||
| Breast Tissue | Mainly used in cancer study and treatment; |
|
| Difficult to treat; | ||
| Pancreas | Mainly used in cancer and diabetes study; |
|
| Hard to treat due to small number of vessels; | ||
| Lungs | Bad regenerative properties; |
|
| Successful replication of functionality by modifying the pressure; | ||
| Brain | Complex due to functionality; |
|
| Differs from person to person; | ||
| Can be recreated by separating the soma and axons; | ||
| Blood | Multiple cell types; |
|
| OoC uses all cell types; | ||
| Need for small chambers; |
FIGURE 2Hydrogel properties and behavior (Liu et al., 2019).
Summary of hydrogel-based microenvironments.
| Biomaterial | Advantage | Disadvantage | Type of OoC used in | References |
|---|---|---|---|---|
| Collagen | Biocompatible; | Need of chemical bonding for stability; | Cardiac; |
|
| Immunogenetic; | Need of mechanic support for the cells to remain intact; | Hepatic; | ||
| Enzymatic degradation; | Vascular; | |||
| Major component of ECM; | Kidney; | |||
| Cells can remodel the ECM gel; | Neurons; | |||
| Solid tumors; | ||||
| Fibrin | Biocompatible; | Weak mechanic properties; | Vascular tissue; |
|
| Noninflammable; | Lungs; | |||
| Biodegradable; | Skeletal muscles; | |||
| Gel modeling at room temperature; | ||||
| Protein delivery system; | ||||
| Hyaluronic Acid | Biocompatible; | Weak mechanic properties; | Metastasis; |
|
| Natural component of ECM; | Tissue barrier; | |||
| Structural component of tissues; | ||||
| Regulable elasticity; | ||||
| Gelatin | Biocompatible; | Need of chemical bonding for stability; | Cardiac; |
|
| Biodegradable; | Vascular; | |||
| Similar composition as collagen; | Muscle; | |||
| Good elasticity; | ||||
| Synthetic biomaterials | Regulable mechanic properties; | Immune responses need to be evaluated; | Cardiac; |
|
| Less variable than natural biomaterials; | Can have cytotoxic effects; | Hepatic; | ||
| Chemically modifiable; | ||||
| Degradable; | ||||
| Can be modelled; | ||||
| Chitosan | Biocompatible; | Mechanical weakness; | Vascular; |
|
| Biodegradable; | Unstable; | |||
| Flexible; | ||||
| Similar structure as glycosaminoglycans; | ||||
| Alginic acid | Biocompatible; | Uncontrolled degradation; | Cardiac; |
|
| Degradable; | Limited protein absorption; | Tumors; | ||
| Missing the binding cells; | Liver; | |||
| Marrow; |
FIGURE 3Organ-on-a-chip using microfluids.
FIGURE 4Electrospun mat possible applications.